Endo Pays $8B For Par Pharmaceuticals To Expand Product Pipeline
May 18, 2015 at 20:41 PM EDT
Endo buys Par Pharmaceuticals to build upon existing product pipeline; investors are wary.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.